CYP24A1 and neoplasm: reported 10 exemples of 1,2,3‐triazol‐1‐yl-benzenesulfonamide derivatives (Figure 3(B)) with different aryl substitutions via CuAAC reaction, with all derivatives showing potent and selective inhibition towards the cytosolic hCA I and II compared to the tumour-associated hCA IX and XII.27